Sort
10,766 grants matching “checkpoint inhibitor”
Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes
$443,381A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$443,233Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$443,233Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
The Role of Schwann Cells in the Progression of Melanoma
$443,178Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
$442,930Andrew J Armstrong · Duke University · R01 · FY2023 · CA
Novel IL-12 Gene Delivery Vehicles for Transformation of Solid Tumors
$442,717Seth M Pollack · Northwestern University At Chicago · R01 · FY2021 · CA
Bone marrow-derived myeloid cell dysregulation in malignant progression of glioma
$442,594Prajwal Rajappa · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · NS
Regulation of the Mitotic Checkpoint by Gsk3
$442,500William R Taylor · University Of Toledo · R15 · FY2017 · GM
Targeting melanoma promoting RNA modification pathway for melanoma therapy.
$442,236Narendra Wajapeyee · University Of Alabama At Birmingham · R01 · FY2025 · CA
Targeting MUC1-C with an antibody drug conjugate for the therapy of advanced prostate cancer
$442,214Donald W. Kufe · Dana-Farber Cancer Inst · R21 · FY2022 · CA
Novel mechanisms regulating PD-1 signaling and function
$442,212Adam Mor · Columbia University Health Sciences · R01 · FY2022 · AI
From the Past to the Future: Chimeric Antigen Receptor T cells for Lymphoid Malignancies
$442,180Joseph Anthony Fraietta · University Of Pennsylvania · P01 · FY2023 · CA
The replication checkpoint and genomic fidelity in skin
$442,018Paul Nghiem · University Of Washington · R01 · FY2010 · AR
Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy
$441,967Stephen Matthew Hatfield · Northeastern University · R01 · FY2024 · EB
Role of Macrophage in Osteoimmunology with Aging
$441,855Zhenqiang Yao · University Of Rochester · R01 · FY2023 · AG
Role of Macrophage in Osteoimmunology with Aging
$441,855Zhenqiang Yao · University Of Rochester · R01 · FY2022 · AG
Project 3: Chemokine modulation in TME for enhanced TLS formation and cross-priming/ recruitment of therapeutic CD8+ TILs
$441,751Walter J Storkus · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$441,736Andrew E Aplin · Wistar Institute · P01 · FY2023 · CA
Targeting ER+ Breast Cancer Through Induced Viral Mimicry
$441,716Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma
$441,695Markus Schober · New York University School Of Medicine · R01 · FY2022 · CA
Checkpoints of TNF Gene Regulation
$441,667Anne Goldfeld · Boston Children'S Hospital · R01 · FY2015 · GM
Regulation of Tumor Immunogenicity in Glioblastoma
$441,658Sze Chun Winson Ho · University Of California, San Francisco · R01 · FY2024 · NS
Targeting NQO1+ tumor to trigger innate and adaptive immunity
$441,498Xiumei Huang · Indiana University Indianapolis · R01 · FY2023 · CA
Targeting Epigenomic Regulators at the Replication Fork in PDAC
$441,252Gwen Lomberk · Medical College Of Wisconsin · R01 · FY2022 · CA
Studies of DNA damage checkpoints
$441,095Scripps Research Institute · R01 · FY2003 · CA